Table 2 Clinicopathological features of extranodal NK/T-cell lymphomas
Patient | Age | Gender | Site | Clinical stage | Treatment | Clinical outcome |
|---|---|---|---|---|---|---|
1 | 69 | Male | Left nasal cavity | IIE | CT (6× CHOP) RT (45 Gy) | Alive 10 years after the first diagnosis without tumor recurrence |
2 | 30 | Male | Right nasal cavity | IIE | CT (4× ACVBP) | Died 4 months after the first diagnosis |
3 | 26 | Male | Left nasal cavity | IIB | CT (4× ACVBP) RT (45 Gy) | Patient lost 1 year after treatment starting |
4 | 39 | Male | Left nasal cavity | IA | CT (4× ACVBP) RT (45 Gy) | Alive 6 years after the first diagnosis without tumor recurrence |
5 | 54 | Male | Palate | IE | CT (6× CHOP) | Died only 2 months after the first diagnosis |
6 | 74 | Male | Sub-mandibular lodge | IV | Surgery CT (6× CHOP) RT (45 Gy) | Alive 5 years after the first diagnosis without tumor recurrence |
7 | 39 | Female | Nasal cavities | IA | CT (4× ACVBP) RT (45 Gy) | Alive 7 years after the first diagnosis without tumor recurrence |
8 | 50 | Male | Soft tissue of ankle | Undetermined | Surgery | Patient lost after tumor resection |
9 | 55 | Male | Skin | IV | CT (6× SMILE) RT (62 Gy) | Died 2 months after CT end with meningeal relapse |